Meeting
2019 Genitourinary Cancers Symposium
Protection of prostate cancer cells from GSK-3β-induced oxidative stress by Il-8 through activating the mTOR signaling pathway.
Authors
Yi Sun
West China Hospital, Sichuan University, Chengdu, China
Yi Sun , Lu Yang , Qiang Wei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 311)
DOI
10.1200/JCO.2019.37.7_suppl.311
Abstract #
311
Poster Bd #
D19
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
In vitro and in vivo investigations of novel 1,4-napthoquinone sulphomethylene carbohydrate conjugates in prostate cancer.
First Author: Tobias Busenbender
Poster
2016 Genitourinary Cancers Symposium
Pre-clinical rationale for combination PI3K and BRD4 inhibition in advanced prostate cancer.
First Author: Paul Toren
Poster
2024 ASCO Genitourinary Cancers Symposium
A double-blinded, placebo-controlled, cross-over pilot trial in healthy men to study the effects of Angelica gigas herbal supplement on prostate cancer–relevant inflammatory cytokines.
First Author: Anne-Laure Strong
Poster
2023 ASCO Annual Meeting
Association of adaptive immunity/inflammatory genes with survival in prostate cancer.
First Author: Austin Hopper